Drug Profile
GDC 0134
Alternative Names: GDC0134; RG-6000Latest Information Update: 28 Dec 2022
Price :
$50
*
At a glance
- Originator Genentech
- Class Neuroprotectants; Small molecules
- Mechanism of Action Mitogen-activated protein kinase kinase kinase 12 inhibitors; Neuron modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Amyotrophic lateral sclerosis
Most Recent Events
- 28 Dec 2022 No recent reports of development identified for phase-I development in Amyotrophic-lateral-sclerosis in Canada (PO, Capsule)
- 28 Dec 2022 No recent reports of development identified for phase-I development in Amyotrophic-lateral-sclerosis in Netherlands (PO, Capsule)
- 28 Dec 2022 No recent reports of development identified for phase-I development in Amyotrophic-lateral-sclerosis in USA (PO, Capsule)